The ID-Card Anti-D contains polyclonal anti-D of human origin within the gel matrix. This card allows the testing of 6 samples. It is especially useful for confirmation of RhD determination, verification of negative reactions or when doubtful results with other methods (such as microplates, automated procedures) have been observed.

ID-Card (Id-n°: 50160):
•Human
•Configuration: 6 x D

Bio-Rad provides Anti-D Reference Reagent for controlling of antibody detection procedures.

Vials (Id-n°: 13010):
•Configuration: 6 x 0.5 mL
•Cell lines: ESD 1 and LHM59/19

The ID-Card DiaClon Anti-Cw is designed for the detection of the presence or absence of the Cw antigen (RH8) on human red blood cell, for manual use as well as on instruments.

For control see ID-Card Control Card A (Id-n°: 52020).

ID-Card (Id-n°: 52010):
•Configuration: 6 x Cw
•Cell line: MS-110

The ID-Card Control Card A is designed to validate the reactions obtained with the ID-Cards
DiaClon Anti-Cw and DiaClon Rh-Subgroups + Cw + K.

ID-Card (Id-n°: 52020):
•Configuration: 6 x ctl

The ID-Cards Anti-K and Anti-k can be used to determine the antigen status of donor blood prior to crossmatching, for confirmation of the antigen after antibody identification, or for paternal/fetal antigen typing in allo-immunised pregnancies. The antibodies of the Kell system have been associated with transfusion reactions and hemolytic disease of the newborn (HDN). The clinical importance of anti-K has resulted in the systematic determination of the K and Cellano antigens in both donors and patients.

ID-Card (Id-n°: 50200):
•Cell lines: MS-56

The antibodies of the Kell system have been associated with transfusion reactions and hemolytic disease of the newborn (HDN). The clinical importance of anti-K has resulted in the systematic determination of the K and Cellano antigens in both donors and patients. The ID-Cards Anti-K and Anti-k can be used to determine the antigen status of donor blood prior to crossmatching, for confirmation of the antigen after antibody identification, or for paternal/fetal antigen typing in allo-immunised pregnancies.

ID-Card
(Id-n°: 50260)
human

M (MNS1) and N (MNS2) antigenic determinants are carried on glycophorin A (GPA), one of the major sialic acid containing structure of the red cell membrane.

ID-Card (Id-n°: 50212):
•Cell line: 9211 9D5 1G10

M (MNS1) and N (MNS2) antigenic determinants are carried on glycophorin A (GPA), one of the major sialic acid containing structure of the red cell membrane.

ID-Card (Id-n°: 50221):
•Cell line: 1422 C7+MN879

M (MNS1) and N (MNS2) antigenic determinants are carried on glycophorin A (GPA), one of the major sialic acid containing structure of the red cell membrane.

ID-Card (Id-n°: 51210):
•Cell line: M: 9211 9D5 1G10, N: 1422 C7+MN879

DiaClon Anti-P1 monoclonal (6 x P1)

ID-Card (Id-n°: 51180):
•Cell line: 650

Lewis antigens are absent or only poorly expressed on red cells from newborns.

ID-Card (Id-n°: 50242):
•Configuration: 6 x Lea
•Cell lines: P3N20V3+LM112/161

Lewis antigens are absent or only poorly expressed on red cells from newborns.

ID-Card (Id-n°: 50250):
•Configuration: 6 x Leb
•Cell lines: LM129/181 (LB1)

Lewis antigens are absent or only poorly expressed on red cells from newborns.

ID-Card
(Id-n°: 51241)

Configuration:
Lea, Leb, ctl/Lea, Leb, ctl

Cell lines:
Lea: P3N20V3 + LM112/161, Leb: LM129/181 (LB1)

The antibodies of the Kidd system are often associated with severe hemolytic transfusion reactions (HTRs), notably delayed reactions. The transfusion of compatible blood in the Kidd system, where antibodies have previously been detected (or are suspected), is therefore important.

ID-Card (Id-n°: 50270):
•Cell line: MS-15

The antibodies of the Kidd system are often associated with severe hemolytic transfusion reactions (HTRs), notably delayed reactions. The transfusion of compatible blood in the Kidd system, where antibodies have previously been detected (or are suspected), is therefore important.

ID-Card (Id-n°: 50280):
•Cell lines: MS-8

The antibodies of the Kidd system are often associated with severe haemolytic transfusion reactions (HTRs), notably delayed reactions. The transfusion of compatible blood in the Kidd system, where antibodies have previously been detected (or are suspected), is therefore important.

ID-Card (Id-n°: 51250):
•Configuration: Jka, Jkb, ctl/Jka, Jkb, ctl
•Cell lines: Jka: MS-15, Jkb: MS-8

Kpa (KEL3), Kpb (KEL4) and Kpc (KEL21) are part of the Kell system (ISBT, number 006). Kpa is present in approximately 2% of the Caucasian population while Kpb is a high frequency (public) antigen. The Kpc antigen has an occurrence of less than 0.01% but up to 0.32% in Japanese. Anti-Kpa and anti-Kpb are less common than anti-K but have similar serological characteristics and are considered to be clinically significant. They may occur after transfusion or by feto-maternal immunization.

ID-Card (Id-n°: 50290):
•Configuration: 6 x Kpa

Kpa (KEL3), Kpb (KEL4) and Kpc (KEL21) are part of the Kell system (ISBT, number 006). Kpa is present in approximately 2% of the Caucasian population while Kpb is a high frequency (public) antigen. The Kpc antigen has an occurrence of less than 0.01% but up to 0.32% in Japanese. Anti-Kpa and anti-Kpb are less common than anti-K but have similar serological characteristics and are considered to be clinically significant. They may occur after transfusion or by feto-maternal immunization.

ID-Card (Id-n°: 50300):
•Configuration: 6 x Kpb

Kpa (KEL3), Kpb (KEL4) and Kpc (KEL21) are part of the Kell system (ISBT, number 006). Kpa is present in approximately 2% of the Caucasian population while Kpb is a high frequency (public) antigen. The Kpc antigen has an occurrence of less than 0.01% but up to 0.32% in Japanese. Anti-Kpa and anti-Kpb are less common than anti-K but have similar serological characteristics and are considered to be clinically significant. They may occur after transfusion or by feto-maternal immunization.

ID-Card (Id-n°: 51260):
•Human
•Configuration: Kpa, Kpb, ctl/Kpa, Kpb, ctl

Antibodies against antigens in the Lutheran system are not often encountered. The antigen-antibody reaction produces small and loose agglutinates in a characteristic mixed-field appearance. The antigens are poorly developed at birth. Allo anti-Lua has not been implicated in transfusion reactions and only rarely as causing mild hemolytic disease of the fetus and newborn (HDFN). Allo anti-Lub has been implicated in mild to moderate transfusion reactions and mild HDFN.

ID-Card
(Id-n°: 50310)
human

Antibodies against antigens in the Lutheran system are not often encountered. The antigen-antibody reaction produces small and loose agglutinates in a characteristic mixed-field appearance. The antigens are poorly developed at birth. Allo anti-Lua has not been implicated in transfusion reactions and only rarely as causing mild hemolytic disease of the fetus and newborn (HDFN). Allo anti-Lub has been implicated in mild to moderate transfusion reactions and mild HDFN.

ID-Card (Id-n°: 50320)

Antibodies against antigens in the Lutheran system are not often encountered. The antigen-antibody reaction produces small and loose agglutinates in a characteristic mixed-field appearance. The antigens are poorly developed at birth. Allo anti-Lua has not been implicated in transfusion reactions and only rarely as causing mild hemolytic disease of the fetus and newborn (HDFN). Allo anti-Lub has been implicated in mild to moderate transfusion reactions and mild HDFN.

ID-Card (Id-n°: 51230):
•Human
•Configuration: Lua, Lub, ctl/Lua, Lub, ctl

Bio-Rad provides testing products for Antigens S and s. The antigens S (MNS3) and s (MNS4) are carried on the human glycophrin B (GPB) molecule and are part of the MNS system. Ss antibodies are not frequently encountered, however, they have both been implicated in rare cases of severe haemolytic disease ot the newborn and rare cases of mild to moderate haemolytic transfusion reactions, and are therefore clinically important. Antigen typing of paternal or fetal/neonatal or donor bloods may also be appropriate, according to the clinical situation.

ID-Card S (Id-n°: 50330):
•Configuration: 6 x S

Test serum ID-Anti-S (Id-n°: 09010):
•Human, 1 x 3.6 mL, 72 tests

Test serum ID-Anti-S (Id-n°: 09010):
•Human, 1 x 5.0 mL, 90 tests (ideal for Automation)

Bio-Rad provides testing products for Antigens S and s. The antigens S (MNS3) and s (MNS4) are carried on the human glycophrin B (GPB) molecule and are part of the MNS system. Ss antibodies are not frequently encountered, however, they have both been implicated in rare cases of severe haemolytic disease ot the newborn and rare cases of mild to moderate haemolytic transfusion reactions, and are therefore clinically important. Antigen typing of paternal or fetal/neonatal or donor bloods may also be appropriate, according to the clinical situation.

ID-Card s (Id-n°: 50340):
•Configuration: 6 x s

Test serum ID-Anti-s (Id-n°: 09110):
•Human, 1 x 3.6 mL, 72 tests

Test serum ID-Anti-s (Id-n°: 09110):
•Human, 1 x 5.0 mL, 90 tests (ideal for Automation)

Bio-Rad provides testing products for Antigens S and s. The antigens S (MNS3) and s (MNS4) are carried on the human glycophrin B (GPB) molecule and are part of the MNS system. Ss antibodies are not frequently encountered, however, they have both been implicated in rare cases of severe haemolytic disease ot the newborn and rare cases of mild to moderate haemolytic transfusion reactions, and are therefore clinically important. Antigen typing of paternal or fetal/neonatal or donor bloods may also be appropriate, according to the clinical situation.

ID-Card S/s (Id-n°: 51280):
•Configuration: S, s, ctl/S, s, ctl

Test serum ID-Anti-S/s (Id-n°: 46190):
•Human, 2 x 1.4 mL, 28 tests

Test serum ID-Anti-S (Id-n°: 09010):
•Human, 1 x 5.0 mL, 90 tests (ideal for automation)

Test serum ID-Anti-s (Id-n°: 09110):
•Human, 1 x 5.0 mL, 90 tests (ideal for Automation)

Test of Antigen S

The antigens S (MNS3) and s (MNS4) are carried on the human glycophrin B (GPB) molecule and are part of the MNS system. Ss antibodies are not frequently encountered, however they have both been implicated in rare cases of severe hemolytic disease of the newborn and rare cases of mild to moderate hemolytic transfusion reactions, and are therefore clinically important. Antigen typing of paternal or fetal/neonatal or donor bloods may also therefore be appropriate, according to the clinical situation.

Test serum ID-Anti-S
(Id-n°: 09010)
human

ID-Card S
(Id-n°: 50330)

Test of Antigen s

The antigens S (MNS3) and s (MNS4) are carried on the human glycophrin B (GPB) molecule and are part of the MNS system. Ss antibodies are not frequently encountered, however they have both been implicated in rare cases of severe hemolytic disease of the newborn and rare cases of mild to moderate hemolytic transfusion reactions, and are therefore clinically important. Antigen typing of paternal or fetal/neonatal or donor bloods may also therefore be appropriate, according to the clinical situation.

Test serum ID-Anti-s
(Id-n°: 09110)
human

ID-Card s
(Id-n°: 50340)

Test of Antigen S and s

The antigens S (MNS3) and s (MNS4) are carried on the human glycophrin B (GPB) molecule and are part of the MNS system. Ss antibodies are not frequently encountered, however they have both been implicated in rare cases of severe hemolytic disease of the newborn and rare cases of mild to moderate hemolytic transfusion reactions, and are therefore clinically important. Antigen typing of paternal or fetal/neonatal or donor bloods may also therefore be appropriate, according to the clinical situation.

Test serum ID-Anti-S/s
(Id-n°: 46190)
human

ID-Card S/s
(Id-n°: 51280)

Bio-Rad provides testing products for Antigen Fya. Both Duffy antigens are fully developed at birth. Fya frequently causes immunisation while Fyb is rarely the cause of immunisation. Anti-Fya and anti-Fyb are practically always of immune origin. They both cause hemolytic transfusion reactions and can, although not frequently, cause hemolytic disease of the newborn (HDN).

ID-Card Fya (Id-n°: 50350):
•Configuration: 6 x Fya

Test serum ID-Anti-Fya (Id-n°: 09210):
•Human, 1 x 3.6 mL, 72 tests

Test serum ID-Anti-Fya (Id-n°: 09210):
•Human, 1 x 5.0 mL, 90 tests (ideal for Automation)

Bio-Rad provides testing products for Antigen Fya and Fyb. Both Duffy antigens are fully developed at birth. Fya frequently causes immunisation while Fyb is rarely the cause of immunisation. Anti-Fya and anti-Fyb are practically always of immune origin. They both cause haemolytic transfusion reactions and can, although not frequently, cause haemolytic disease of the newborn (HDN).

ID-Card Fyb (Id-n°: 50360):
•Configuration: 6 x Fyb

Test serum ID-Anti-Fyb (Id-n°: 09310):
•Human, 1 x 3.6 mL, 72 tests

Test serum ID-Anti-Fyb (Id-n°: 09310):
•Human, 1 x 5.0 mL, 90 tests (ideal for Automation)

Test of Antigen Fya

Both Duffy antigens are fully developed at birth. Fya frequently causes immunization while Fyb is rarely the cause of immunization. Anti-Fya and anti-Fyb are practically always of immune origin. They both cause hemolytic transfusion reactions and can, although not frequently, cause hemolytic disease of the new-born (HDN).

Test serum ID-Anti-Fya
(Id-n°: 09210)
human

ID-Card Fya
(Id-n°: 50350)

Test of Antigen Fyb

Both Duffy antigens are fully developed at birth. Fya frequently causes immunization while Fyb is rarely the cause of immunization. Anti-Fya and anti-Fyb are practically always of immune origin. They both cause hemolytic transfusion reactions and can, although not frequently, cause hemolytic disease of the new-born (HDN).

Test serum ID-Anti-Fyb
(Id-n°: 09310)
human

ID-Card Fyb
(Id-n°: 50360)

The ID-Anti-Dia contains rare, lyophilized human antisera for the indirect antiglobulin test (IAT) with The ID-Card LISS/Coombs. When an alloantibody specificity is suspected or defined in either a donor or a patient’s blood sample, the red cells should be tested with an appropriate antiserum to confirm lack of the corresponding antigen. Specific antigen-negative blood may be required for crossmatching prior to transfusion to a recipient with a known alloantibody. Typing of paternal or fetal/neonatal antigens on red cells can also be an important procedure in assessing and monitoring risk in an allo-immunised pregnancy.

Vial (Id-n°: 09080):
•According to availability